Exenatide Once Monthly Showed Positive Results In Phase 2 Study

Links shared publicly online about this topic.

  • 440
    total visits

Exenatide Once Monthly Showed Positive Results In Phase 2 Study

medicalnewstoday.com

Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN), Eli Lilly and Company (NYSE: LLY) and Alkermes, Inc. (Nasdaq: ALKS) announced positive results from a phase 2 study evaluating the effects of a once-mo

View full resource at medicalnewstoday.com

Tags: Diabetes, Diabetes Type 2 Medication, Diabetes Medication, Pharma, Phase 2 Clinical Trial, Byetta, Eli Lilly and Company

  • Share

Most Recently Shared on March 14, 2011 at 10:06 am By:

NatureRevEndo NatureRevEndocrinol

Once monthly exenatide showed positive results on glycemic control in phase II study http://mnt.to/3Scx #diabetes #T2DM (via @mnt_diabetes)

1 year ago...

Also Shared By:

MNT Diabetes News MNT Diabetes News

Exenatide Once Monthly Showed Positive Results In Phase 2 Study | Diabetes | Type 2 Diabetes | Diabetes Mellitus | Keyvive.com

keyvive.com — “Exenatide Once Monthly Showed Positive Results In Phase 2 Study | Diabetes | Type 2 Diabetes | Diabetes Mellitus | Keyvive.comView full resource at keyvive.com

  • View Related
  • Share

Most Recently Shared on March 14, 2011 at 4:15 pm By:

keyvive Aimee Greenholtz ePatient

Exenatide Once Monthly Showed Positive Results In Phase 2 Study: Amylin Pharmaceuticals, Inc… http://goo.gl/fb/rBt5n

1 year ago...

Exenatide Once Monthly Showed Positive Results in Phase 2 Study: PR Newswire Business News - MSN Money

money.msn.com — “Exenatide Once Monthly Showed Positive Results in Phase 2 Study: PR Newswire Business News - MSN MoneyView full resource at money.msn.com

  • View Related
  • Share

Most Recently Shared on March 11, 2011 at 4:01 am By:

Night_shift_Doc Dr. Anthony Blash Doctor, Pharmacist, and PharmD

Exenatide Once Monthly Showed Positive Results in Phase 2 Study: PR Newswire Business News http://on-msn.com/h3vnMW (via @news360app)

1 year ago...

Phase 2 Study of Once-Monthly Exenatide for Type 2 Diabetes - MPR

empr.com — “Amylin announced positive results from its Phase 2 study of a once-monthly injectable suspension formulation of exenatide in patients with type 2 diabetes.View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on March 10, 2011 at 3:53 pm By:

eMPR MPR Medical Publisher

MPR News: Phase 2 Study of Once-Monthly Exenatide for Type 2 Diabetes: Amylin announced positive results from it... http://bit.ly/gNS5Uw

1 year ago...

Exenatide Once Monthly Showed Positive Results in Phase 2 Study - Drugs.com MedNews

drugs.com — “Investigational GLP-1 Treatment Improved Glucose Control with Just One Dose per Month (BUSINESS Mar 10, 2011 - Amylin Pharmaceuticals, Inc. (Nasdaq AMLN), Eli LView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on March 10, 2011 at 2:09 pm By:

Drugs_Devices Drugs and Devices OW OW Health

Exenatide Once Monthly Showed Positive Results in Phase 2 Study: Investigational GLP-1 Treatment Improved ... http://bit.ly/fVp4nM #drug

1 year ago...

Advertisement